Glucose transporters: expression, regulation and cancer.
about
Is cancer a metabolic disease?The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesCrystal structure of a glucose/H+ symporter and its mechanism of action.Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancerReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectIdentification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesCo-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.The prototypical H+/galactose symporter GalP assembles into functional trimersN-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma.Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerGLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugatesBiomarkers of resistance to radiation therapy: a prospective study in cervical carcinomaPre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.Fluorescent fructose derivatives for imaging breast cancer cellsUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.Effect of Livingstone Potato (Plectranthus esculenthus N.E.Br) on Diabetes and Its Complications in Streptozotocin Induced Diabetes in Rats.Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary ReportKrüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.Use of unripe plantain (Musa paradisiaca) in the management of diabetes and hepatic dysfunction in streptozotocin induced diabetes in rats.The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.Novel Approaches to Imaging Tumor MetabolismFructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells.Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose TransportersImpact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxelCancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cellsFasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET.Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib.Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.Glucose conjugation for the specific targeting and treatment of cancer.
P2860
Q26852241-0858826E-D4E3-48DF-BD77-4ABAABE32A37Q27025579-362788A2-3F6C-40F9-BF46-368787225336Q27680370-825982DD-CD4D-4BFE-AD17-B60E9038FAC2Q28067736-F757824A-709D-48B3-AFE5-10BC872CDCE5Q28077883-C93D8CC9-02DB-41DA-B21B-580BDA135D6AQ28553394-1DE60097-C05C-48ED-A486-376B4F1A6447Q33583028-4EF47224-E2B8-44C5-88C8-93DE1C9A6287Q33722813-F02E6D13-860C-4430-9DD7-4306C4DC4EC0Q33739782-1E1F8E44-12CF-4619-B475-9BA2A51086D0Q33756650-72657A94-DF5B-48C8-A182-D50D8D82D10CQ33881902-21AAB4B5-E0E3-4D0F-84E5-2A95AB40C950Q33889236-6DAF314C-5032-45DC-BA7E-EA52F4403B58Q33912942-3C2C64D4-F067-4690-81B4-6E98D250F8CFQ34011842-508A7E53-F7B5-4D06-B775-B38FFE60BE4AQ34094417-04AC0FDA-FC8F-44DE-B723-DB25EAAF0B9FQ34204238-EF8D307E-9500-4A0D-A60F-F4FB217F5898Q34332053-E683BD22-E8BC-43DD-B041-47D05B7743C2Q34404031-6E1AFEF6-4A64-4735-B88F-15EF9691335FQ34791680-FB2CE5AA-7F89-465D-8AF0-59330FFDA220Q35085017-8FBF26E4-A88B-485C-8EED-97315472A9E7Q35204494-01A92374-4E7D-4E32-9424-ADBD57C1DB3DQ35697789-F17774FE-74F3-4DA6-955C-710B18385E5BQ35700192-B7F4BD22-AA6E-4027-AF97-80781A1AE44DQ35703462-BDE5F43A-7309-4A62-911F-29C995D1C147Q35753643-452649F6-5D49-479E-841B-021D344D0E04Q35882212-6B0F4DA8-A310-4E72-8477-BFAC28F73D58Q36010195-7D392175-22DE-4BE5-8E0E-690873928CC2Q36110504-BDCE0389-72B6-4CA5-ACF8-1BFC72CDFACDQ36162383-DC46DBF3-0CD3-4FD1-BD3D-8E6CA2B0BD85Q36194195-2B9653E6-8EC8-4D10-B3B7-B0D7972BFB24Q36350991-EE11ECEB-2D26-4012-9B18-770FEBC6321EQ36381518-D8C7E026-FCF1-4BFA-B8E0-D03F72D11F0DQ36544964-BE78E891-996E-441A-9DE2-16B3BD532E26Q36594091-5910B32D-F059-4152-A59D-C668F873FD70Q36792366-3DCBEFD3-5348-4D64-BDEC-748F350F077DQ36928877-29B750C2-6FB1-4C98-84F9-92F0EA0012C2Q36958371-7160E874-A689-475F-A6E1-163561DD1382Q36971711-5881A259-542C-4EDB-8187-7A69EA13073BQ37062935-04145643-AA69-4B9E-85FE-0140F8ADCDF7Q37200539-9BF3CC46-4D00-40DD-85AF-C6D33B76550E
P2860
Glucose transporters: expression, regulation and cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glucose transporters: expression, regulation and cancer.
@ast
Glucose transporters: expression, regulation and cancer.
@en
Glucose transporters: expression, regulation and cancer.
@nl
type
label
Glucose transporters: expression, regulation and cancer.
@ast
Glucose transporters: expression, regulation and cancer.
@en
Glucose transporters: expression, regulation and cancer.
@nl
prefLabel
Glucose transporters: expression, regulation and cancer.
@ast
Glucose transporters: expression, regulation and cancer.
@en
Glucose transporters: expression, regulation and cancer.
@nl
P1433
P1476
Glucose transporters: expression, regulation and cancer
@en
P2093
Gareth I Owen
Rodolfo A Medina
P356
10.4067/S0716-97602002000100004
P577
2002-01-01T00:00:00Z